Journals / Türk Kardiyoloji Derneği Arşivi / 2012 / Cilt: 40 - Sayı: 5

A late coronary aneurysm after sirolimus stent implantation which was treated with coronary graft stent

Sirolimus salınımlı stent implantasyonu sonrasında geç dönemde gelişen koroner arter anevrizmasının greft stent ile tedavisi

Pages
440–443
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was treated with a coronary stent graft successfully.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Summary– Drug eluting stents are being used frequently because of their less restenotic properties.
📊
Key Findings & Data:A 57-year-old male presented with dyspnea and typical angina on effort.
💡
Conclusion & Impact:It was treated with a coronary stent graft successfully.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Summary– Drug eluting stents are being used frequently because of their less restenotic properties. However, their effect on preventing neo-intimal hyperplasia may cause many adverse effects such as coronary artery aneurysm (CAA). We report a case that presented with a CAA which was the latest developed CAA after the implantation of drug eluting stents in literature so far. A 57-year-old male presented with dyspnea and typical angina on effort. Coronary angiography was performed. A large CAA was detected at the site of a drug eluting stent which was implanted in the LAD artery 5.5 years ago. It was treated with a coronary stent graft successfully.

Özet

İlaç salınımlı stentler restenoz önleyici özelliklerinden dolayı sık olarak kullanılır. Ancak, damar içi hiperplaziyi önleyici etkisi nedeniyle koroner arter anevrizması (KAA) oluşumu gibi yan etkiye neden olabilir. Bu yazıda daha önce ilaç salınımlı stent uygulanan ve literatürde şimdiye kadar en uzun süre sonra KAA gelişen bir hasta sunuldu. Elli yedi yaşında erkek hasta eforla gelen nefes darlığı ve göğüs ağrısı yakınmasıyla hastaneye başvurdu. Yapılan koroner anjiyografide, 5.5 yıl önce sol ön inen artere uygulanan sirolimus salınımlı stent bölgesinde geniş bir KAA saptandı. Bu lezyon başarılı şekilde koroner stent greft ile onarıldı.

🔖

Cite This Article

DİNDAR, İ., ÖZDEN, K., FOTBOLCU, H., ŞENGÜL, C. (2022). A late coronary aneurysm after sirolimus stent implantation which was treated with coronary graft stent. Türk Kardiyoloji Derneği Arşivi, Cilt: 40 - Sayı: 5, 440–443. https://ajindex.com/articles/633041

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-48
  2. Biondi-Zoccai GG, Moretti C, Lotrionte M, Sheiban I. Safety of drug-coated stents. Expert Opin Drug Saf 2008;7:597-606
  3. Grube E, Lansky A, Hauptmann KE, Di Mario C, Di Sciascio G, Colombo A, et al. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial. J Am Coll Cardiol 2004;44:1368-72
  4. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109:701-5
  5. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-10
  6. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202
  7. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41
  8. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006;47:2108-11
  9. Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 2005;111:900-5
  10. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:1002-5
  11. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-9
  12. Aoki J, Kirtane A, Leon MB, Dangas G. Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv 2008;1:14-21
  13. Süselbeck T, Haghi D, Borggrefe M, Kaden JJ. Percutaneous treatment of